mesowatch
HomeJ&J Delays Appeal of $2.1 Billion Verdict
divider

J&J Delays Appeal of $2.1 Billion Verdict Over COVID-19 Issues

J&J hits pause on the 2.1billion verdict

Johnson & Johnson is hitting the pause button on its Supreme Court appeal of a $2.1 billion judgment tied to its talcum powder products.

In an April 22 filing with the high court, Johnson & Johnson’s attorneys asked the court to delay distributing its March 2 petition and brief until May 11 due to pandemic-related issues.

“The COVID-19 pandemic presents personal and logistical challenges for [Johnson & Johnson’s] counsel, who must balance their work commitments — including this case — with continued childcare and other responsibilities, all while working fully remotely,” the letter states.

Ovarian Cancer Claims

The appeal centers on a multi-billion dollar verdict against the pharmaceutical powerhouse last June by the Missouri Court of Appeals for the Eastern District. The verdict was in favor of 22 women who claimed that regular use of Johnson & Johnson talcum products had given them ovarian cancer and also argued that the company had known for decades that its talcum products were laced with asbestos.

Johnson & Johnson has repeatedly denied that its talcum-based products contain asbestos and argued in its appeal that Missouri’s decision to combine all of these different complaints into a mass tort was fundamentally unfair.

“The jury was confronted with 22 different plaintiffs with dramatically different cancer-risk profiles, prognoses, and talc use,” the petition stated. “The mass trial papered over these differences, allowing the jury to overlook significant weaknesses in individual plaintiffs’ claims — and to infer causation from the number of plaintiffs before it.”

Many of these same points were rejected by the Missouri appellate court, which noted that the various plaintiffs’ allegations “arose out of the same basic injuries, same defect, same alleged duty, and same causes of action.”

Pressed for Time

Regarding the requested delay, the letter explains that a rebuttal filing posted on April 19 by attorneys for 20 of the women who won the verdict came earlier than Johnson & Johnson’s attorneys expected and was difficult to juggle with their current caseload and the difficulties that COVID-19 represents.

The high court granted the request a day later.

Two of the attorneys representing the ovarian cancer victims before the high court are well known: Ken Starr, whose investigation of Whitewater ultimately led to Bill Clinton’s 1998 impeachment, and John Ashcroft, who served as attorney general under George W. Bush.

Matthew Davis

Reading Time: 1 mins

Published On: April 28, 2021

Matthew Davis - author

Matthew Davis is a freelance journalist who has covered civil litigation for a variety of publications. He joined Mesowatch in 2016 and covers asbestos litigation developments in the U.S., as well as newsworthy asbestos cases.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer